MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Progressive myoclonic epilepsy ataxia syndrome associated with NUS1 gene mutation

    R. Vasireddy, M. Bensalem-Owen, Z. Guduru (Lexington, USA)

    Objective: To describe a rare case of NUS1 gene mutation related progressive epilepsy myoclonus ataxia syndrome. Background: Pathogenic variants of NUS1 gene have been associated…
  • 2023 International Congress

    Drug-induced Parkinsonism and nonmotor symptoms: a case of gustatory rhinorrhea

    S. Casanova, A. Cabral, M. Branco (Vila Nova Gaia, Portugal)

    Objective: We aim to emphasize the relevance of contemplating nonmotor symptoms as possible features of drug-induced parkinsonism, and the utmost importance of further investigation in…
  • 2023 International Congress

    Investigation of superficial brain stimulation (SBS) in Parkinsonian rats as a non-invasive alternative treatment for patients with movement disorders

    G. Weistroffer, J. Blagg, M. Tashli, R. Hadimani, D. Kumbhare, M. Baron (Richmond, USA)

    Objective: To investigate repetitive transcranial magnetic stimulation (rTMS) in parkinsonian rats as a non-invasive, malleable superficial brain stimulation (SBS) alternative to DBS. Background: DBS is…
  • 2023 International Congress

    Acute-onset parkinsonism secondary to bilateral extrapontine myelinolysis of the basal ganglia: case report

    N. Sarhan (Zagazig, Egypt)

    Objective: Although rapid osmolar correction, mainly in the setting of hyponatremia is the main risk factor of osmotic demyelination syndrome, the pathogenesis of the syndrome…
  • 2023 International Congress

    Acute laryngeal stridor in the emergency department: pandemic or additional sign?

    F. Gomes, C. Silva, D. Damas, I. Carvalho, I. Cunha, A. Brás, A. Morgadinho, F. Moreira (Coimbra, Portugal)

    Objective: To highlight the importance of early recognition of the broader spectrum of clinical features of MSA and specially the sleep-related breathing disorders, as stridor.…
  • 2023 International Congress

    Evaluation of a novel Phosphodiesterase 5 inhibitor as a potential therapeutic agent in P301S transgenic mouse model of tauopathy.

    S. Elfarrash, S. Eldusoky, M. Abdel-Halim, M. Salama, S. El-Khodery, M. Youssef (Mansoura, Egypt)

    Objective: In the current study, we evaluated a newly developed compound with a 1,3,5-trisubstituted pyrazoline scaffold with an improved PDE5 inhibitory potency as a potential…
  • 2023 International Congress

    Linking volume of tissue activated to neural oscillations in deep brain stimulation

    A. Kutuzova, C. Graef, B. Lonergan, Y. Tai, S. Haar (London, United Kingdom)

    Objective: Exploring the effect of deep brain stimulation (DBS) settings on neural oscillations in Parkinson’s disease (PD) patients with subthalamic nucleus (STN) DBS and their…
  • 2023 International Congress

    Diabetic striatopathy presenting without hyperkinetic movements

    S. Bhalja, C. Sarvakar, S. Garg (Ahmedabad, India)

    Objective: To demonstrate a case of Diabetic striatopathy presenting without hyperkinetic movements Background: Diabetic striatopathy is an uncommon neurological complication associated with poorly controlled Diabetes Mellitus…
  • 2023 International Congress

    Obsessive-Compulsive symptoms in Parkinson’s Disease: beyond the Impulse Control Disorders

    D. Damas, M. Fernandes, I. Carvalho, C. Fernandes, A. Araújo, I. Cunha, J. Lemos, F. Moreira (Coimbra, Portugal)

    Objective: To characterize the obsessive-compulsive symptoms (OCS) and Impulse Control Disorders (ICD) in patients with Parkinson’s Disease (PD), as well as explore the correlation between…
  • 2023 International Congress

    Stiff-Person Syndrome: Diagnosis and Experimental Models

    D. Labunskiy, S. Kiryukhina, N. Kolmykova, N. Kurgaev (Saransk, Russian Federation)

    Objective: Locked-in syndrome is a syndrome that is characterized by the lack of an adequate response of the patient to external, including verbal, stimuli due…
  • « Previous Page
  • 1
  • …
  • 620
  • 621
  • 622
  • 623
  • 624
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley